Microalbuminuria
|
WikiDoc Resources for Microalbuminuria |
|
Articles |
|---|
|
Most recent articles on Microalbuminuria Most cited articles on Microalbuminuria |
|
Media |
|
Powerpoint slides on Microalbuminuria |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Microalbuminuria at Clinical Trials.gov Trial results on Microalbuminuria Clinical Trials on Microalbuminuria at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Microalbuminuria NICE Guidance on Microalbuminuria
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Microalbuminuria Discussion groups on Microalbuminuria Patient Handouts on Microalbuminuria Directions to Hospitals Treating Microalbuminuria Risk calculators and risk factors for Microalbuminuria
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Microalbuminuria |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Microalbuminuria occurs when a malfunctioning kidney leaks small amounts of albumin into the urine.
Diagnosis
The level of albumin protein produced by Microalbuminuria cannot be detected by urine dipstick methods. A microalbumin urine test determines the presence of the albumin in urine. In a properly functioning body, albumin is not normally present in urine because it is filtered from the bloodstream by the kidneys.
Microalbuminuria is diagnosed either on 24-hour urine collections (20 to 200 µg/min) or, more commonly, if elevated concentrations (30 to 300mg/L) on at least two occasions.[1]. Albumin levels above these values is called "macroalbuminuria", or sometimes just albuminuria.
To compensate for the variable possible urine concentration on spot-check samples, it is more typical in the UK to compare the amount of albumin in the sample against its concentration of creatinine. This is termed the Albumin/creatinine ratio (ACR) and microalbuminuria is defined as ACR ≥2.5 mg/mmol (male) or ≥3.5 mg/mmol(female).[2]
Significance
- an indicator of subclinical cardiovascular disease
- marker of vascular endothelial dysfunction
- an important prognostic marker for kidney disease
- increasing microalbuminuria level during the first 48 hours after admission to an intensive care unit predicts elevated risk for acute respiratory failure , multiple organ failure , and overall mortality
References
- Abid O, Sun Q, Sugimoto K, Mercan D, Vincent JL (2001). "Predictive value of microalbuminuria in medical ICU patients: results of a pilot study". Chest. 120 (6): 1984–8. PMID 11742932.
- Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD (2000). "Glomerular permselectivity in early stages of overt diabetic nephropathy". Kidney Int. 58 (5): 2129–37. doi:10.1111/j.1523-1755.2000.00386.x. PMID 11044234.
- Heart Outcomes Prevention Evaluation Study Investigators (2000). "Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy". Lancet. 355 (9200): 253–9. PMID 10675071.
- Lemley KV, Abdullah I, Myers BD; et al. (2000). "Evolution of incipient nephropathy in type 2 diabetes mellitus". Kidney Int. 58 (3): 1228–37. doi:10.1046/j.1523-1755.2000.00223.x. PMID 10972685.
- Lièvre M, Marre M, Chatellier G; et al. (2000). "The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group". Controlled clinical trials. 21 (4): 383–96. PMID 10913814.
- Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P (2001). "The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes". N. Engl. J. Med. 345 (12): 870–8. PMID 11565519.
Footnotes
- ↑ "Person—microalbumin level (measured), total micrograms per minute N[NNN].N". Retrieved 2007-07-05.
- ↑ "Proteinuria". UK Renal Association. Dec 15, 2005.